Effects of Sedation, TEmperature and Pressure After Cardiac Arrest and REsuscitation on Major Adverse Kidney Events (STEPCARE-MAKE)
NCT07579390 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3500
Last updated 2026-05-14
Summary
The STEPCARE-MAKE study is a predefined sub-study of the large Sedation, TEmperature and Pressure after Cardiac Arrest and REsuscitation (STEPCARE) trial, which evaluates the effects of three interventions in comatose adult patients resuscitated from out-of-hospital cardiac arrest. In this sub-study, all 3500 participants enrolled in the main trial are assessed for major adverse kidney events (MAKE) and creatinine kinetics.
Conditions
- Acute Kidney Failure
- Renal Replacement Therapy for Acute Kidney Injury in ICU
- Sedation in Intensive Care Unit Patients
- Sedation in the ICU
- Sedation in Intensive Care
- Blood Pressure
- Mean Arterial Pressure Targets
- Temperature
- Fever
- Resuscitated Sudden Cardiac Death
- Out of Hospital Cardiac Arrest
- Cardiac Arrest (CA)
Interventions
- DEVICE
-
Feedback-controlled temperature device
If core body temperature exceeds 37.7°C a feedback-controlled device will be used and set at 37.5°C
- OTHER
-
High MAP
A MAP target of \>85mmHg will be used. Vasopressors will be titrated to this target during 36h
- OTHER
-
Deep sedation
Deep sedation for at least 36h
- OTHER
-
Fever control without a device
Management of fever in the ICU without a device
- OTHER
-
Low MAP
A MAP target of \>65mmHg will be used. Vasopressors will be titrated to this target during 36h
- OTHER
-
Minimal sedation
A strategy of minimal sedation in the ICU, sedation used only as needed to facilitate transport, imaging and invasive procedures
Sponsors & Collaborators
-
Helsinki University Central Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-08-17
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- Australia
- Belgium
- Estonia
- Finland
- Germany
- Italy
- Luxembourg
- New Zealand
- Norway
- Saudi Arabia
- Singapore
- Sweden
- Switzerland
- United Kingdom
Study Locations
More Related Trials
-
CRRT for Glutamate Elimination After Cardiac Arrest
NCT02963298 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Catheter Placement for Renal Replacement Therapy in Patients With Acute Kidney Injury
NCT02200120 ·Status: COMPLETED
-
Evaluation of Regional Anticoagulation With Citrate in Extended Hemodialysis
NCT04297839 ·Status: SUSPENDED ·Phase: PHASE3
-
Methylene Blue for the Prevention of Hypotension During Hemodialysis
NCT05092165 ·Status: COMPLETED ·Phase: PHASE2
-
Dexmedetomidine Pharmacokinetics During Continuous Renal Replacement Therapy (CRRT)
NCT01314209 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Cytokine Removal by CRRT in Pediatric Sepsis
NCT00537693 ·Status: COMPLETED ·Phase: NA
-
Nafamostat Mesylate Versus Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy in Sepsis-Associated Acute Kidney Injury
NCT07518303 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Influence Continuous Veno-venous Hemodialysis the Autoregulation
NCT01376531 ·Status: COMPLETED
-
Effect of Citrate on the Coagulation System in Patients Receiving CRRT
NCT02486614 ·Status: COMPLETED
-
The Effect of Nafamostat Mesilate in Prolonging Filter Patency With Patients on Continuous Renal Replacement Therapy
NCT01761994 ·Status: COMPLETED ·Phase: PHASE4
-
Citrate Versus Heparin Anticoagulation: Effect on Molecules Clearances
NCT01839578 ·Status: UNKNOWN ·Phase: NA
-
Safety and Effect of Low-Energy Extracorporeal Shockwave Therapy (ESWT) on the Renal Allograft in Transplant Recipients.
NCT03602807 ·Status: UNKNOWN ·Phase: NA
-
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
NCT01400893 ·Status: TERMINATED ·Phase: NA
-
Investigating Different Anticoagulants for Renal Replacement Therapy
NCT02669589 ·Status: COMPLETED ·Phase: PHASE4
-
Continuous Renal Replacement Therapy for Acute Kidney Injury by Cooling Blood
NCT04103307 ·Status: WITHDRAWN ·Phase: PHASE2
-
Modalities of Renal Replacement Therapy in Pediatric Acute Kidney Injury
NCT01569698 ·Status: TERMINATED
-
Hemodynamic and Respiratory Tolerance of Intermittent Hemodialysis in Critically Ill Patients
NCT04444765 ·Status: COMPLETED
-
Safety Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Renal Failure
NCT01072682 ·Status: COMPLETED ·Phase: NA
-
Long-term Survival and Renal Outcomes in Critically Ill Patients After Acute Kidney Injury: Swedish Multi-centre Cohort Study
NCT02424747 ·Status: COMPLETED
-
Oxidative Stress and Circulating Nuclear DNA (cfDNA) in Acute Kidney Injury and Continuous Renal Replacement Therapies.
NCT06646328 ·Status: TERMINATED ·Phase: PHASE4
-
Hemostatic Profiles in Pediatric CKD
NCT05064267 ·Status: COMPLETED
-
Registry for HF20 for Pediatric CRRT Under Emergency Use Authorization
NCT04836026 ·Status: COMPLETED
-
Safety and Efficacy of a Selective Cytopheretic Device (SCD) in Pediatric Patients With Acute Kidney Injury (AKI).
NCT02820350 ·Status: COMPLETED ·Phase: NA
-
Ischemic Preconditioning to Prevent Acute Kidney Injury
NCT02167152 ·Status: COMPLETED ·Phase: NA
-
Perfusion - Pressure - Creatinine Trial
NCT01408420 ·Status: COMPLETED ·Phase: NA